The European Commission's Research Directorate General, in cooperation with the Enterprise and Industry Directorate, is consulting stakeholders on their needs in relation to transnational research cooperation and knowledge transfer between public research organizations (including universities, polytechnics and other public sector organizations involving research) and industry, and on possible actions in this field.
The Commission's work in this area is largely based on the recognition that sub-optimal research cooperation and knowledge transfer between PROs and industry is a key weakness in the European research and innovation system, notes a press statement on the issue.
Existing measures often too parochial
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze